학술논문

RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy
Document Type
Journal
Source
JOURNAL OF HEPATOLOGY; AUG 2020, 73 pS51-pS51, 1p. Supplement: 1
Subject
Language
English
ISSN
16000641